Risks and benefits of prophylaxis against venous thromboembolism in orthopaedic surgery

Journal of Bone and Joint Surgery - Series B

Volumn 82, Issue 4, 2000, Pages 475-479

  Gillespie, W ^a   Murray, D ^b   Gregg, P J ^c   Warwick, D ^d  

^a UNIVERSITY OF OTAGO   (New Zealand)

^b NUFFIELD ORTHOPAEDIC CENTRE   (United Kingdom)

^c NEWCASTLE UNIVERSITY   (United Kingdom)

^d UNIVERSITY HOSPITAL SOUTHAMPTON NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; PLACEBO;

ARTICLE; BLEEDING; BLOOD CLOTTING DISORDER; CLINICAL TRIAL; COMPRESSION THERAPY; DRUG EFFICACY; EPISTAXIS; GASTROINTESTINAL HEMORRHAGE; HIGH RISK PATIENT; HIP FRACTURE; HUMAN; LUNG EMBOLISM; ORTHOPEDIC SURGERY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PUMP; RISK BENEFIT ANALYSIS; STROKE; THROMBOEMBOLISM; THROMBOSIS PREVENTION; TOTAL HIP PROSTHESIS; TOTAL KNEE REPLACEMENT; UNITED KINGDOM; VEIN THROMBOSIS;

EID: 0034024268     PISSN: 0301620X     EISSN: None     Source Type: Journal    
DOI: 10.1302/0301-620X.82B4.10452     Document Type: Article

References (40)

1. Thromboembolic Risk Factors (THRIFT) Consensus Group. Risk of and prophylaxis for venous thromboembolism in hospital patients. Br Med J 1992;305:567-74.
2. Prophylaxis of Venous Thromboembolism. Edinburgh. Scottish Intercollegiate Guidelines Network, 1995.
3. Salzman EW, Hirsh J. Prevention of venous thromboembolism. In: Colman RW, Hirsh J, Marder V, Salzman EW, eds. Hemostasis and thrombosis: basic principles and clinical practice. New York, Lippincot. 1982:986.
4. Murray DW, Carr AJ, Bulstrode CJK. Pharmacological prophylaxis and total hip replacement. J Bone Joint Surg [Br] 1995;77-B:3-5.
5. Murray DW, Britton AR, Bulstrode CJK. Thromboprophylaxis and death after total hip replacement. J Bone Joint Surg [Br] 1996;78-B:863-70.
6. Fender D, Harper WM, Thompson JR, Gregg PJ. Mortality and fatal pulmonary embolism post primary total hip replacement: results from a regional hip register. J Bone Joint Surg [Br] 1997.
7. Francis RM, Brenkel IJ. Survey of use of thromboprophylaxis for routine total hip replacement by British orthopaedic surgeons. Br J Hosp Med 1997;57:427-31.
8. McNally MA, Cooke EA, Harding ML, Mollan RA. Attitudes to, and utilization of, low molecular weight heparins in joint replacement surgery. J R Coll Surg Edinb 1997;42:407-9.
9. Rodgers A, Gray H, MacMahon S. Pharmacological thromboprophylaxis in hip and knee surgery: a survey of New Zealand orthopaedic surgeons. Aust NZ J Surg 1994;64:167-72.
10. Todd CJ, Freeman CJ, Camilleri-Ferrante C, et al. Differences in mortality after fracture of the hip: the East Anglian audit. BMJ 1995;310:904-8.
11. Collins R, Scrimgeour A, Yusuf S, Peto R. Reduction in fatal pulmonary embolism and venous thrombosis by perioperative administration of subcutaneous heparin: an overview of results of randomized trials in general, orthopaedic and urological surgery. N Engl J Med 1988;18:1162-73.
12. Collins R, Baigent C, Sandercock P, Peto R. Antiplatelet therapy for thromboprophylaxis: the need for careful consideration of the evidence from randomised trials. Br Med J 1994;309:1215-17.
13. Planes A, Vochelle C, Darmon JY, et al. Risk of deep venous thrombosis after hospital discharge in patients having undergone total hip replacement: double blind randomised comparison of enoxaparin versus placebo. Lancet 1996;348:224-8.
14. Bergquist D, Benoni G, Bjorgell O, et al. Low-molecular weight heparin (enoxaparin) as prophylaxis against venous thromboembolism after total hip replacement. N Engl J Med 1996;335:696-700.
15. White RH, Romano PS, Zhou H, Rodrigo J, Bargar M. Incidence and time course of thromboembolic outcomes following total hip or knee arthroplasty. Arch Intern Med 1998;158:1525-31.
16. Leclerc JR, Gent M, Hirsh J, Geerts WH, Ginsberg JS. The incidence of symptomatic venous thromboembolism during and after prophylaxis with enoxaparin: a multi-institutional cohort study of patients who underwent hip or knee arthroplasty: Canadian Collaborative Group. Arch Intern Med 1998;158:873-8.
17. Lowe GDO. Prediction of postoperative deep vein thrombosis. Thromb Haemost 1997;78:47-52.
18. McNally MA, Kernohan WG, Croal SA, Mollan RAB. Deep venous thrombosis in orthopaedic patients: improving the specificity of diagnosis. Clin Orthop 1993;295:275-80.
19. Cogo A, Lensing WA, Koopman MMW, et al. Compression ultrasonography for diagnostic management of patients with clinically suspected deep vein thrombosis: prospective cohort study. Br Med J 1998;316:17-20.
20. Ascani A, Radicchia S, Parise P, Nenci GG, Agnelli G. Distribution and occlusiveness of thrombi in patients with surveillance detected deep vein thrombosis after hip surgery. Thromb Haemost 1996;75:239-41.
21. Robinson KS, Anderson DR, Gross M, et al. Ultrasonographic screening before hospital discharge for venous thrombosis after arthroplasty: the post-arthroplasty screening study: a randomised, controlled trial. Ann Intern Med 1997;127:39-45.
22. Ciccone WJ, Fox PS, Neumyer M, et al. Ultrasound surveillance for asymptomatic deep venous thrombosis after joint replacement. J Bone Joint Surg [Am] 1998;80-A:1167-74.
23. Jorgensen LN, Wille-Jorgensen P, Hauch O. Prophylaxis of post-operative thromboembolism with low molecular weight heparins. Br J Surg 1993;80:689-704.
24. Handoll HHG, Farrar MJ, McBirnie, et al. Prophylaxis using heparin, low molecular weight heparin and physical methods against deep vein thrombosis and pulmonary embolism in hip fracture surgery. The Cochrane Library (database on disk and CDROM). The Cochrane Collaboration. Oxford: Update Software, 1997. Updated quarterly. Available from BMJ Publishing Group, London.
25. Warwick DJ, Ferez JV, Vickery C, Bannister GC. Chronic venous insufficiency after total hip replacement. J Arthroplasty 1995;11:529-33.
26. Milne AA, Ruckley C. Venous insufficiency following deep vein thrombosis. Vase Med Rev 1994;5:241-8.
27. Skinner JA, Zahn H, Porteous MJL, Thomas EM, Kakkar VV. Does DVT matter in hip surgery? Venous functional sequelae at five years. J Bone Joint Surg [Br] 1996;78-B:Suppl I, 63.
28. Serafini S, Beltrametti C, Siragusa S, Barone M, Piovella F. Postthrombotic syndrome after asymptomatic postoperative deep vein thrombosis: an inception cohort study. Thromb Haemost 1997;77:718.
29. Nurmohamed MT, Rosendaal FR, Büller HR, et al. Low-molecular-weight heparin versus standard heparin in general and orthopaedic-surgery: a meta-analysis. Lancet 1992;340:152-6.
30. Lassen MR, Borris LC, Christiansen HM, et al. Clinical trials with low molecular weight heparin in the prevention of postoperative thromboembolic complications: A meta-analysis. Sem Thromb Haemost 1991;17:284-90.
31. Howard AW, Aaron SD. Low molecular weight heparin decreases proximal and distal deep venous thrombosis following total knee arthroplasty: a meta-analysis of randomized trials. Thromb Haemost 1998;79:902-6.
32. Wells PS, Lensing AW, Hirsh J. Graduated compression stockings in the prevention of postoperative venous thromboembolism: a meta-analysis. Arch Intern Med 1994;154:67-72.
33. Hui ACW, Heras-Palou C, Dunn I, et al. Graded compression stockings for prevention of deep-vein thrombosis after hip and knee replacement. J Bone Joint Surg [Br] 1996;78-B:550-4.
34. Warwick D, Harrison J, Glew D, et al. Comparison of the use of a foot pump with the use of low-molecular-weight heparin for the prevention of deep-vein thrombosis after total hip replacement: a prospective, randomised trial. J Bone Joint Surg [Am] 1998;80-A:1158-66.
35. Harrison J, Warwick DJ, Coast J. Economics of thromboprophylaxis in total hip replacement. Pharmacoeconomics 1997;12:30-41.
36. Geerts WH, Jay RM, Code KI, et al. A comparison of low dose heparin wilh low-molecular weight heparin as prophylaxis against venous thromboembolism after major trauma. N Engl J Med 1996;335:701-7.
37. Warwick D, Williams MN, Bannister GC. Death and thromboembolic disease after total hip replacement: a series of 1162 cases with no routine chemical prophylaxis. J Bone Joint Surg [Br] 1995;77-B:6-10.
38. Warwick DJ, Whitehouse S. Symptomatic venous thromboembolism after total knee replacement. J Bone Joint Surg [Br] 1997;79-B:780-6.
39. Ansari S, Warwick D, Ackroyd CE, Newman JH. Incidence of fatal pulmonary embolism after 1390 knee arthroplasties without routine prophylactic anticoagulation, except in high risk cases. J Arthroplasty 1997;12:599-602.
40. Anti-platelet Trialists, Collaboration. Collaborative overview of randomised trials of anti-platelet therapy: III. Reduction in venous thrombosis and pulmonary embolism by anti-platelet prophylaxis among surgical and medical patients. BMJ 1994;308:235-46.